Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

about

Improving Immunotherapy Through Glycodesign

P2860

Q59132146-A11B3AEB-0FF0-40D8-B315-DC637105706D

P2860

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

Item

http://www.wikidata.org/entity/Q44852748

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

@en

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

@nl

type

Item

label

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

@en

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

@nl

prefLabel

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

@en

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

@nl

P1476

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

@en

P2093

Dimiter S Dimitrov

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Weizao Chen

http://www.w3.org/2001/XMLSchema#string

Yang Feng

http://www.w3.org/2001/XMLSchema#string

Zhongyu Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of human GDP-mannose 4,6-dehydratase and reconstitution of GDP-fucose biosynthesis in vitro

Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs

Fc glycans of therapeutic antibodies as critical quality attributes

Molecular basis for immune complex recognition: a comparison of Fc-receptor structures

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity

Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1

The crystal structure of rabbit IgG-Fc

The structural basis for catalytic function of GMD and RMD, two closely related enzymes from the GDP-d-rhamnose biosynthesis pathway

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose

Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans

P304

1554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.01554

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29181010

http://www.w3.org/2001/XMLSchema#string

P932

5693878

http://www.w3.org/2001/XMLSchema#string

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

about

P2860

P2860

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932